Charlestown, MA, United States of America

Leonora Balaj

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 3.6

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2017-2024

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Leonora Balaj: Innovator in Medical Diagnostics

Introduction

Leonora Balaj is a prominent inventor based in Charlestown, MA (US), known for her significant contributions to the field of medical diagnostics. With a total of three patents to her name, she has made remarkable strides in understanding and diagnosing various medical conditions.

Latest Patents

One of her latest patents is titled "Extracellular mRNA markers of muscular dystrophies in human urine." This patent describes methods for diagnosing and monitoring subjects with diseases associated with aberrant splicing, based on detecting properly spliced isoforms and mis-spliced isoforms in a urine sample from the subject. Another notable patent is "Cancer-related biological materials in microvesicles." This invention discloses methods for assaying a biological sample from a subject by analyzing components of microvesicle fractions to aid in risk assessment, diagnosis, prognosis, or treatment direction for various diseases.

Career Highlights

Leonora Balaj is affiliated with The General Hospital Corporation, where she applies her expertise in medical research and diagnostics. Her work has been instrumental in advancing the understanding of complex medical conditions through innovative diagnostic methods.

Collaborations

Throughout her career, she has collaborated with esteemed colleagues, including Xandra O Breakefield and Casey Maguire, contributing to a rich environment of research and innovation.

Conclusion

Leonora Balaj's work exemplifies the impact of innovation in the medical field, particularly in diagnostics. Her patents reflect a commitment to improving patient outcomes through advanced research and technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…